Prescrire IN ENGLISH - HOME

Register online | Log in | My Prescrire

Issue contents

About Prescrire

english.prescrire.org > Dossiers > Medicines in Europe

Dossiers > Theme:

Medicines in Europe

Prescrire and its partners participate actively in the debate over the key questions of healthcare policy in Europe.

Themes

Prescrire Awards
Medicines in Europe

Recap: working together to improve healthcare policy in Europe

Statements issued since 2002 by Prescrire and its partners on the key issues surrounding healthcare policy in Europe, including pharmacovigilance, patient information, paediatric medicines and more.

Transparency of European drug regulatory authorities:
improvements needed

Drug regulatory agencies should function in an open and transparent manner in order to serve patients' and citizens' interests. Without transparency, there can be no means to ensure trust in decision-making. Real transparency is an indispensable prerequisite to restore EU citizens' confidence in the agencies' decisions.

Pharmacovigilance: a crucial issue for the health and safety of all Europeans

Prescrire and its partners continue in their campaign to reorient the European Commission's proposals on pharmacovigilance toward public health and a real reinforcement of safety for European citizens.

Patient information in Europe

Prescrire and its partners regularly participate in the European debate, working in favour of citizens' access to relevant information and against legalising disguised direct-to-consumer advertising (DTCA) in Europe.

Patient safety in Europe: time for action!

This Dossier contains the response filed in May 2008 by the International Network of Safe Medication Practice Centres (now known as IMSN) in answer to the EU Commission consultation on patient safety.